| DEAE-dextran | diethylaminoethyl-dextran |
| PAMAM | polyamidoamine |
| PEI | polyethylenimine |
| H5WYG | GLFHAIAHFIHGGWHGLIHGWYG (one letter amino acid code) |
| pDNA | plasmid |
| Y or N | yes or no for whether in vitro or in vivo studies were done |
| DP | degree of polymerization |
| ODN | oligodeoxynucleotide |
| HMW | high molecular weight |
| LMW | low molecular weight |
| CHK6HC | HMW reducible peptide containing multiple CHKKKKKKHC repeats |
| CH6K3H6C | HMW reducible peptide containing multiple CHHHHHHKKKHHHHHHC repeats |
| GFP | green fluorescent protein |
| cRGD | cyclic RGD ligand with oxidized cysteines that has the sequence, CRGDCF |
| HK | Histidine-Lysine peptide |
| PEG | polyethylene-glycol |
| PEG-CH12K18 | PEGylatated copolymer made up of 12 histidines and 18 lysines |
| PEG-CK30 | PEGylated polymer made up of 30 lysines |
| shRNA | Plasmid expressing short hairpin RNAi targeting luciferase |
| cRGD-hK | cyclic RGD conjugated to N-terminal of polylysine in which every 4th lysine modified by a histidine |
| KGH6 | 6th generation lysine dendrimer with terminal ends modified by histidines |
| H2K4b-T | a 4-branched peptide with a predominant sequence of -HHK- and a histidine-rich domain off the C-terminal end of the 3-lysine core (i.e., Tail) |
| H3K8b | 8-branched peptide with a predominate sequence of -HHHK |
| H2K4b, H2K | a 4-branched and linear HK peptide with a predominant sequence of -HHK- |
| FGF-2 | fibroblast growth factor-2 |
| dKH | diffuse distribution of KH sequences with 6 multiple repeats |
| cKH | cluster KH—6 multiple repeats of clustered lysines and histidines |
| LAH4 | peptide with sequence of KKALLALALHHLAHLALHLALALKKA |
| O6H6 | blocked copolymer containing six ornithines and histidines |
| K16 | peptide with 16 lysines |
| DC | dendritic cells |
| TAT | cell-penetrating peptide with sequence of RKKRRQRRRR |
| C-H5-TAT-H5-C | reducible peptide with sequence of CHHHHHRKKRRQRRRRHHHHHC |
| Gtt | glutaroyl-triethylene tetramine |
| Stp | succinoyl tetraethylene pentamine |
| Sph | succinoyl pentaethylene hexamine |
| cMET | tyrosine kinase receptor |
| siEG5-KLK | conjugate of siRNA targeting EG5 and apoptotic peptide, KLK |
| PAMAM-His3-Arg | polyamidoamine dendrimer with terminal ends modified by -HHHR |
| PAMAM-His2-Arg | polyamidoamine dendrimer with terminal ends modified by -HHR |
| PAMAM-His3-Arg | polyamidoamine dendrimer with terminal ends modified by -HR |
| PAMAM-Arg | polyamidoamine dendrimer with terminal ends modified by -R |
| lPEI | Linear PEI |
| H-lPEI | histidinylated linear PEI |
| UA | Urocanic acid |
| PTEN | Phosphatase and tensin homolog protein |
| Cs | Chitosan |
| R6H6-Cs | Chitosan modified with a blocked co-peptide of RRRRRRHHHHHH |
| CDP | cyclodextrin |
| imCDP | cyclodextrin modified with imidazoles |
| DMAEA | 2-dimethylaminoethylamino |
| PIDP | polyphosphazene polymer modified with imidazoles and DMAEA |
| PDAP | polyphosphazene polymer modified with DMAEA |
| PBAE | poly(β-amino esters |
| PLH-Me | Polyhistidine containing methylhistidines, dimethylhistidine, and unmodified |
| CM-PLH | carboxymethylated-polyhistidine histidines |
| KALA | a cationic amphipathic peptide |
| H6-20 | lipopeptide containing six histidines (also named NickFect70) |
| siGADPH | siRNA targeting GADPH |
| NRP-1 | neuropilin-1 |
| Chol | cholesterol |
| PD-1 | program cell death protein 1 |
| LPD | ternary complex (lipopolyplex) made up liposomes, polymer, and DNA |
| LPR | ternary complex (lipopolyplex) made up liposomes, polymer, and RNA |
| hK-liposomes | hK peptide conjugated to liposomes |
| His-Lip | Histidine-modified liposome |
| MART-1 | Melanoma Antigen Recognized by T cells 1 |
| LAMP1 | lysosomal-associated membrane protein 1 |
| MART-1-LAMP1 | Fusion of the MART1 and LAMP1 proteins |
| MAN-LPR | Mannosylated targeted RNA lipopolyplex |
| Im-Hist-Lip | Imidazole-histamine modified liposomes |
| PEG-HpK | PEG-histidylated-polylysine |
| Tri-man | tri-antenna of α-D-mannopyranoside |
| Tri-Man-Im-Hist-Lip | Tri-Man ligand coupled to Im-Hist-liposome |
| DOTAP | 1,2-dioleoyl-3-trimethylammonium-propane |
| IPEI | linear polyethylenimine containing 16% histidines |
| MSN | mesoporous silica nanoparticles |
| MSN-NH2 | mesoporous silica nanoparticles with aminopropyltriethoxysilane |
| MSN-His | mesoporous silica nanoparticles with aminopropyltriethoxysilane and histidines |
| SL-IDMSN | MSN modified by imidazoles |
| ZIF-8 | zinc imidazole framework |
| VLP | virus-like particles |